| R-HSA-109582 |
Hemostasis |
| R-HSA-1280218 |
Adaptive Immune System |
| R-HSA-1280218 |
Adaptive Immune System |
| R-HSA-1643685 |
Disease |
| R-HSA-1643685 |
Disease |
| R-HSA-166658 |
Complement cascade |
| R-HSA-166663 |
Initial triggering of complement |
| R-HSA-166786 |
Creation of C4 and C2 activators |
| R-HSA-168249 |
Innate Immune System |
| R-HSA-168249 |
Innate Immune System |
| R-HSA-168256 |
Immune System |
| R-HSA-168256 |
Immune System |
| R-HSA-173623 |
Classical antibody-mediated complement activation |
| R-HSA-198933 |
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| R-HSA-202733 |
Cell surface interactions at the vascular wall |
| R-HSA-2029480 |
Fcgamma receptor (FCGR) dependent phagocytosis |
| R-HSA-2029480 |
Fcgamma receptor (FCGR) dependent phagocytosis |
| R-HSA-2029481 |
FCGR activation |
| R-HSA-2029481 |
FCGR activation |
| R-HSA-2029482 |
Regulation of actin dynamics for phagocytic cup formation |
| R-HSA-2029485 |
Role of phospholipids in phagocytosis |
| R-HSA-2168880 |
Scavenging of heme from plasma |
| R-HSA-2173782 |
Binding and Uptake of Ligands by Scavenger Receptors |
| R-HSA-2454202 |
Fc epsilon receptor (FCERI) signaling |
| R-HSA-2454202 |
Fc epsilon receptor (FCERI) signaling |
| R-HSA-2730905 |
Role of LAT2/NTAL/LAB on calcium mobilization |
| R-HSA-2730905 |
Role of LAT2/NTAL/LAB on calcium mobilization |
| R-HSA-2871796 |
FCERI mediated MAPK activation |
| R-HSA-2871809 |
FCERI mediated Ca+2 mobilization |
| R-HSA-2871809 |
FCERI mediated Ca+2 mobilization |
| R-HSA-2871837 |
FCERI mediated NF-kB activation |
| R-HSA-5653656 |
Vesicle-mediated transport |
| R-HSA-5663205 |
Infectious disease |
| R-HSA-5663205 |
Infectious disease |
| R-HSA-5690714 |
CD22 mediated BCR regulation |
| R-HSA-9658195 |
Leishmania infection |
| R-HSA-9658195 |
Leishmania infection |
| R-HSA-9662851 |
Anti-inflammatory response favouring Leishmania parasite infection |
| R-HSA-9662851 |
Anti-inflammatory response favouring Leishmania parasite infection |
| R-HSA-9664323 |
FCGR3A-mediated IL10 synthesis |
| R-HSA-9664323 |
FCGR3A-mediated IL10 synthesis |
| R-HSA-9664407 |
Parasite infection |
| R-HSA-9664407 |
Parasite infection |
| R-HSA-9664417 |
Leishmania phagocytosis |
| R-HSA-9664417 |
Leishmania phagocytosis |
| R-HSA-9664422 |
FCGR3A-mediated phagocytosis |
| R-HSA-9664422 |
FCGR3A-mediated phagocytosis |
| R-HSA-9664433 |
Leishmania parasite growth and survival |
| R-HSA-9664433 |
Leishmania parasite growth and survival |
| R-HSA-977606 |
Regulation of Complement cascade |
| R-HSA-983695 |
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers |
| R-HSA-983695 |
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers |
| R-HSA-983705 |
Signaling by the B Cell Receptor (BCR) |
| R-HSA-983705 |
Signaling by the B Cell Receptor (BCR) |